SGS Expands Viral Trials: ‘Less Volunteers, Less Cost to Client’
SGS says the expansion of its Belgian unit will offer a new approach in its clinical trials involving smaller sample sizes.
Archives for February 14, 2013
AMRI Deal a Catalyst for Pharma Growth says Codexis
AMRI has teamed up with biocatalysis firm Codexis to develop cheaper, faster and greener ways of manufacturing APIs.
Protalix Looks to Capitalize on Plant-Based Manufacturing Technology
Protalix Biotherapeutics is attempting to use its US FDA-approved Gaucher's disease treatment as a proof of concept and springboard for its plant-based cell manufacturing technology.
Merck: ‘In-House API Production Remains Important Strategy’
Merck says it will keep in-house API production capacity as it continues to evaluate its manufacturing strategy.
Hospira’s Manufacturing Woes Continue with US Device Plant 483
Hospira says bringing medical device manufacturing operations up to code will take 'a lot of work' after Lake Forest, Illinois plant is hit with US FDA Form 483.
PPD Expands Central Lab Services in Brussels, Singapore
PPD has expanded its central lab testing services at its Brussels and Singapore labs and will offer additional services in microbiology, peripheral blood mononuclear cell and molecular pathology services.